159 related articles for article (PubMed ID: 24369732)
1. Expression and prognostic significance of CIP2A in cutaneous malignant melanoma.
Shi F; Ding Y; Ju S; Wu X; Cao S
Biomarkers; 2014 Feb; 19(1):70-6. PubMed ID: 24369732
[TBL] [Abstract][Full Text] [Related]
2. Expression of CIP2A in renal cell carcinomas correlates with tumour invasion, metastasis and patients' survival.
Ren J; Li W; Yan L; Jiao W; Tian S; Li D; Tang Y; Gu G; Liu H; Xu Z
Br J Cancer; 2011 Dec; 105(12):1905-11. PubMed ID: 22075943
[TBL] [Abstract][Full Text] [Related]
3. Cellular localization of CIP2A determines its prognostic impact in superficial spreading and nodular melanoma.
Flørenes VA; Emilsen E; Dong HP; Førsund M; Holm R; Slipicevic A
Cancer Med; 2015 Jun; 4(6):903-13. PubMed ID: 25663244
[TBL] [Abstract][Full Text] [Related]
4. CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells.
Chen XD; Tang SX; Zhang JH; Zhang LT; Wang YW
Oncol Rep; 2017 Aug; 38(2):1005-1012. PubMed ID: 28656258
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth.
Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J
Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612
[TBL] [Abstract][Full Text] [Related]
6. CIP2A is a predictor of poor prognosis in colon cancer.
Teng HW; Yang SH; Lin JK; Chen WS; Lin TC; Jiang JK; Yen CC; Li AF; Chen PC; Lan YT; Lin CC; Hsu YN; Wang HW; Chen KF
J Gastrointest Surg; 2012 May; 16(5):1037-47. PubMed ID: 22328001
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CIP2A in clear cell renal cell carcinoma promotes cellular epithelial-mesenchymal transition and is associated with poor prognosis.
Tang Q; Wang Q; Zeng G; Li Q; Jiang T; Zhang Z; Zheng W; Wang K
Oncol Rep; 2015 Nov; 34(5):2515-22. PubMed ID: 26327467
[TBL] [Abstract][Full Text] [Related]
8. CIP2A is overexpressed in non-small cell lung cancer and correlates with poor prognosis.
Dong QZ; Wang Y; Dong XJ; Li ZX; Tang ZP; Cui QZ; Wang EH
Ann Surg Oncol; 2011 Mar; 18(3):857-65. PubMed ID: 20842459
[TBL] [Abstract][Full Text] [Related]
9. CIP2A is overexpressed in human endometrioid adenocarcinoma and regulates cell proliferation, invasion and apoptosis.
Yu N; Zhang T; Zhao D; Cao Z; Du J; Zhang Q
Pathol Res Pract; 2018 Feb; 214(2):233-239. PubMed ID: 29274810
[TBL] [Abstract][Full Text] [Related]
10. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells.
Chen KF; Liu CY; Lin YC; Yu HC; Liu TH; Hou DR; Chen PJ; Cheng AL
Oncogene; 2010 Nov; 29(47):6257-66. PubMed ID: 20729919
[TBL] [Abstract][Full Text] [Related]
11. Protein phosphatase 2A (PP2A) inhibitor CIP2A indicates resistance to radiotherapy in rectal cancer.
Birkman EM; Elzagheid A; Jokilehto T; Avoranta T; Korkeila E; Kulmala J; Syrjänen K; Westermarck J; Sundström J
Cancer Med; 2018 Mar; 7(3):698-706. PubMed ID: 29441695
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of CIP2A in Esophagogastric Junction Adenocarcinoma: A Study of 65 Patients and a Meta-Analysis.
Li Y; Wang M; Zhu X; Cao X; Wu Y; Fang F
Dis Markers; 2019; 2019():2312439. PubMed ID: 31534561
[TBL] [Abstract][Full Text] [Related]
13. Constitutive CHK1 Expression Drives a pSTAT3-CIP2A Circuit that Promotes Glioblastoma Cell Survival and Growth.
Khanna A; Thoms JAI; Stringer BW; Chung SA; Ensbey KS; Jue TR; Jahan Z; Subramanian S; Anande G; Shen H; Unnikrishnan A; McDonald KL; Day BW; Pimanda JE
Mol Cancer Res; 2020 May; 18(5):709-722. PubMed ID: 32079743
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of CIP2A in cholangiocarcinoma and correlation with poor prognosis.
Xu P; Huang Q; Xie F; Xu XL; Shao F
Hepatogastroenterology; 2013 Jun; 60(124):669-72. PubMed ID: 24046827
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of sCIP2A levels in breast cancer.
Xing ML; Lu YF; Wang DF; Zou XY; Zhang SX; Yun Z
Eur Rev Med Pharmacol Sci; 2016; 20(1):82-91. PubMed ID: 26813457
[TBL] [Abstract][Full Text] [Related]
16. Ets1 and Elk1 transcription factors regulate cancerous inhibitor of protein phosphatase 2A expression in cervical and endometrial carcinoma cells.
Pallai R; Bhaskar A; Sodi V; Rice LM
Transcription; 2012; 3(6):323-35. PubMed ID: 23117818
[TBL] [Abstract][Full Text] [Related]
17. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
[TBL] [Abstract][Full Text] [Related]
18. CIP2A is highly expressed in hepatocellular carcinoma and predicts poor prognosis.
He H; Wu G; Li W; Cao Y; Liu Y
Diagn Mol Pathol; 2012 Sep; 21(3):143-9. PubMed ID: 22847158
[TBL] [Abstract][Full Text] [Related]
19. Expression patterns of microRNA-218 and its potential functions by targeting CIP2A and BMI1 genes in melanoma.
Wei Y; Du Y; Chen X; Li P; Wang Y; Zang W; Zhao L; Li Z; Zhao G
Tumour Biol; 2014 Aug; 35(8):8007-15. PubMed ID: 24839010
[TBL] [Abstract][Full Text] [Related]
20. Upregulated ankyrin repeat-rich membrane spanning protein contributes to tumour progression in cutaneous melanoma.
Liao YH; Hsu SM; Yang HL; Tsai MS; Huang PH
Br J Cancer; 2011 Mar; 104(6):982-8. PubMed ID: 21343931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]